CHD4 and atypical endometrial hyperplasia: In endometrial cancer, CHD4 is involved in the progression from endometrial atypical hyperplasia (AH) to uterine endometrioid carcinoma (EC) [28, 29], and mutations in CHD4 can promote endometrial tumorigenesis [30].